Q3 2024 Bruker Corp Earnings Call Transcript
Key Points
- Bruker Corp (BRKR) reported a 16.4% year-over-year increase in Q3 2024 revenues, reaching approximately $864 million.
- The company achieved a 3.1% organic revenue growth, with the Bruker Scientific Instruments (BSI) segment growing by 3.8% year-over-year.
- Strategic acquisitions contributed significantly to revenue growth, adding 12.5% to the top line.
- Bruker Corp (BRKR) anticipates further sequential margin improvements in Q4 2024.
- The company is optimistic about the impact of China's stimulus orders, which are expected to benefit the P&L in the second half of 2025.
- Bruker Corp (BRKR) lowered its fiscal year 2024 guidance due to delayed recoveries in the biopharma and China markets.
- Non-GAAP operating margin decreased by 510 basis points year-over-year to 14.9%, primarily due to dilution from strategic acquisitions.
- The company reported a decline in non-GAAP EPS by 18.9% from the previous year, attributed to acquisition-related expenses and lower profitability.
- Biopharma and China markets have been weaker than expected, impacting overall revenue growth.
- The backlog remains elevated, with a book-to-bill ratio below one, indicating potential challenges in converting orders to revenue.
No Good day, and welcome to the Bruker Corporation Third Quarter 2024 earnings call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's remarks, there will be an opportunity to ask questions. To ask a question. You may press star then one on your touch-tone phone. To withdraw your question, please press star then two. Please note, this event is being recorded. I'd now like to turn the conference over to Joe Kostka, Director of Investor Relations. Please go ahead.
Good morning. I would like to welcome everyone to Bruker Corporation's Third Quarter 2024 earnings conference call. My name is Joe Kostka, and I'm the Director of Bruker Investor Relations. Joining me on today's call are Frank H. Laukien, Ph.D. our President and CEO, and Gerald N. Herman, our EVP and CFO. In addition to the earnings release we issued earlier today. During today's conference call, we will be referencing a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
